Clinical Outcomes of Definitive Intensity-Modulated Radiation Therapy With Fluorodeoxyglucose-Positron Emission Tomography Simulation in Patients With Locally Advanced Cervical Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 4, 2010, Pages 1085-1091

  Kidd, Elizabeth A ^a   Siegel, Barry A ^b,c   Dehdashti, Farrokh ^b,c   Rader, Janet S ^a,c   Mutic, Sasa ^a   Mutch, David G ^a,c   Powell, Matthew A ^a,c   Grigsby, Perry W ^a,b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Washington University in St Louis School of Medicine   (United States)

Author keywords

Cervix; FDG PET CT; Image guidance; IMRT; Non IMRT

Indexed keywords

ADVERSE EVENTS; BRACHYTHERAPY; CAUSE-SPECIFIC SURVIVAL; CERVICAL CANCERS; CLINICAL OUTCOME; COHORT STUDIES; COMMON TERMINOLOGY CRITERIA; CONCURRENT CHEMOTHERAPY; CUMULATIVE HAZARD FUNCTION; CURATIVE INTENT; FDG-PET; FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHIES; IMAGE GUIDANCES; INTENSITY-MODULATED RADIATION THERAPY; POST TREATMENT; RECURRENCE-FREE SURVIVAL; STATISTICAL SIGNIFICANCE; TREATMENT RESPONSE;

CHEMOTHERAPY; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; POSITRONS; RADIOTHERAPY; RISK ANALYSIS; RISK ASSESSMENT; TOXICITY;

PHYSICAL THERAPY;

CESIUM; CISPLATIN; FLUORODEOXYGLUCOSE;

ADULT; ADVANCED CANCER; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CAUSE SPECIFIC SURVIVAL; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG UPTAKE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; IRRADIATION; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE DISTRIBUTION; RADIATION HAZARD; RADIATION INJURY; RECURRENCE RISK; RECURRENT CANCER; SCORING SYSTEM; SIMULATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UROGENITAL TRACT DISEASE; UTERINE CERVIX CANCER;

BRACHYTHERAPY; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 77953563709     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.06.041     Document Type: Article

References (35)

1. Ellenson L.H., and Wu T.C. Focus on endometrial and cervical cancer. Cancer Cell 5 (2004) 533-538
2. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 58 (2008) 71-96
3. Plummer M., and Franceschi S. Strategies for HPV prevention. Virus Res 89 (2002) 285-293
4. Morris M., Eifel P.J., Lu J., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340 (1999) 1137-1143
5. Rose P.G., Bundy B.N., Watkins E.B., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 (1999) 1144-1153
6. Keys H.M., Bundy B.N., Stehman F.B., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340 (1999) 1154-1161
7. Wang-Chesebro A., Xia P., Coleman J., et al. Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 66 (2006) 654-662
8. Guerrero Urbano M.T., Henrys A.J., Adams E.J., et al. Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels. Int J Radiat Oncol Biol Phys 65 (2006) 907-916
9. Salama J.K., Mell L.K., Schomas D.A., et al. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: A multicenter experience. J Clin Oncol 25 (2007) 4581-4586
10. Roeske J.C., Lujan A., Rotmensch J., et al. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 48 (2000) 1613-1621
11. Portelance L., Chao K.S., Grigsby P.W., et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 51 (2001) 261-266
12. Lujan A.E., Mundt A.J., Yamada S.D., et al. Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys 57 (2003) 516-521
13. Chen M.F., Tseng C.J., Tseng C.C., et al. Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent Cisplatin and intensity-modulated pelvic radiotherapy: Comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 67 (2007) 1438-1444
14. Kavanagh B.D., Schefter T.E., Wu Q., et al. Clinical application of intensity-modulated radiotherapy for locally advanced cervical cancer. Semin Radiat Oncol 12 (2002) 260-271
15. Subak L.L., Hricak H., Powell C.B., et al. Cervical carcinoma: Computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol 86 (1995) 43-50
16. Grigsby P.W., Dehdashti F., and Siegel B.A. FDG-PET evaluation of carcinoma of the cervix. Clinical Positron Imaging 2 (1999) 105-109
17. Grigsby P. PET and PET/CT in cervical and uterine cancer. In: Wahl R.L. (Ed). Principles and practices of PET and PET/CT. 2nd ed (2008), Lippincott Williams & Wilkins, Philadelphia 348-354
18. Schwarz J.K., Siegel B.A., Dehdashti F., et al. Association of post-therapy positron emission tomography with tumor response and survival in cervical carcinoma. J Am Med Assoc 298 (2007) 2289-2295
19. Perez C.A., and Kavanagh B.D. Uterine cervix. In: Perez C.A., Brady L.W., Halperin E.C., et al. (Eds). Principles and practice of radiation oncology. 4th ed (2003), Lippincott, Williams & Williams, Philadelphia 1800-1915
20. Macdonald D.M., Lin L.L., Biehl K., et al. Combined intensity-modulated radiation therapy and brachytherapy in the treatment of cervical cancer. Int J Radiat Oncol Biol Phys 71 (2008) 618-624
21. Mutic S., Dempsey J.F., Bosch W.R., et al. Multimodality image registration quality assurance for conformal three-dimensional treatment planning. Int J Radiat Oncol Biol Phys 51 (2001) 255-260
22. Miller T.R., and Grigsby P.W. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int J Radiat Oncol Biol Phys 53 (2002) 353-359
23. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. JAMA 53 (1958) 457-481
24. Breslow N. A generalized Kruskal-Wallis test for comparing K samples subject to unequal patterns of censorship. Biometrika 57 (1970) 579-594
25. Cox D.R. Regression models and life tables. J R Stat Soc 34 (1972) 187-220
26. National Cancer Institute. Concurrent Chemoradiation for Cervical Cancer. Washington, DC; 1999.
27. Grigsby P.W., Siegel B.A., and Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 19 (2001) 3745-3749
28. Caldwell C.B., Mah K., Ung Y.C., et al. Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: The impact of 18FDG-hybrid PET fusion. Int J Radiat Oncol Biol Phys 51 (2001) 923-931
29. Fox J.L., Rengan R., O'Meara W., et al. Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer?. Int J Radiat Oncol Biol Phys 62 (2005) 70-75
30. Steenbakkers R.J., Duppen J.C., Fitton I., et al. Reduction of observer variation using matched CT-PET for lung cancer delineation: A three-dimensional analysis. Int J Radiat Oncol Biol Phys 64 (2006) 435-448
31. Eifel P.J., Levenback C., Wharton J.T., et al. Time course and incidence of late complications in patients treated with radiation therapy for FIGO Stage IB carcinoma of the uterine cervix. International Journal of Radiation Oncology Biology Physics 32 (1995) 1289-1300
32. Roeske J.C., Lujan A., Rotmensch J., et al. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. Int J Radiat Oncol Biol Phys 48 (2000) 1613-1621
33. Lujan A.E., Mundt A.J., Yamada S.D., et al. Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys 57 (2003) 516-521
34. Beriwal S., Gan G.N., Heron D.E., et al. Early clinical outcome with concurrent chemotherapy and extended-field, intensity-modulated radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 68 (2007) 166-171
35. Chen M.F., Tseng C.J., Tseng C.C., et al. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients. Cancer J 14 (2008) 200-206